Exclusive Zantac-Related Breast Cancer Leads that are Ready to Litigate

Zantac and Breast Cancer

Zantac and Breast Cancer

A peer-reviewed study by the American Association for Cancer Research examined the relationship between Zantac and breast cancer.

Obtaining solid cases involving breast cancer by Zantac users might be the hardest task facing a plaintiff law firm.”
— Edward Lott,Ph.D., M.B.A.

ALLENTOWN, PA, US, August 13, 2020 /EINPresswire.com/ -- ForLawFirmsOnly Marketing, Inc., helps law firms handling personal injury cases or class action lawsuits attract clients. These firms not only want to be profitable, they help their communities. Their clients include those who genuinely need legal help, including women who have breast cancer due to Zantac use.

A peer-reviewed study by the American Association for Cancer Research and the American Society of Preventive Oncology examined the relationship between H2 antihistamine-blockers like Zantac and breast cancer. The 2008 study found an increased risk of a type of breast cancer.

Zantac is a histamine H2-receptor antagonist, also known as an H2 blocker. It was used to treat duodenal and gastric ulcers and prevent their return by limiting the amount of acid produced in the stomach. Over the counter versions were used to relieve or prevent heartburn, acid indigestion, and sour stomach. The Food and Drug Administration asked the makers of Zantac and related products to recall them in April.

Though the study didn’t find a causal link between ranitidine (Zantac’s active ingredient) and breast cancer in general, it did suggest that those regularly using these medications had an increased risk of ductal carcinoma. It found, “current use of ranitidine may increase risk of hormone receptor-positive ductal carcinoma…”

Ranitidine increases the levels of the hormone prolactin. Both animal and laboratory data suggest prolactin is involved in the creation of tumors. This relationship and postmenopausal breast cancer risk makes the use of H2 blockers a potential risk factor.

A study found chances of a type of ductal carcinoma increase with the use of ranitidine. The study found women aged 55 to 79 using H2 blockers with ranitidine were 2.4 times more likely to develop estrogen receptor-positive/progesterone receptor-positive ductal carcinoma, compared to others who didn’t use the medication.

ForLawFirmsOnly Marketing, Inc., connects law firms to the potential clients it needs. Obtaining solid cases involving breast cancer by Zantac users might be the hardest task facing a plaintiff law firm. ForLawFirmsOnly Marketing, Inc.’s Zero Risk cases can make that difficult task a thing of the past.

How does it work? ForLawFirmsOnly Marketing, Inc., connects those who need legal help with those who provide it, providing signed Zantac cases.
• Prospects search for lawyers or legal information, find a web property, sponsored ad, social advert, or a TV ad and call a tracking number or complete a form to Request a Free Consultation with a local law firm.
• The advertising is focused on Google Maps, organic SEO (Google, Bing, Yahoo), Google Ads, Bing, and Facebook. Depending on the ideal client profile, ForLawFirmsOnly Marketing, Inc., may turn to other, more productive platforms.
• Unlike other ad agencies, we have experience with several different ad platforms, so the company uses the right one for the job. ForLawFirmsOnly Marketing, Inc., focuses on mobile marketing, using voice search, to capture some of the best and highest converting leads.
• Our proven screening process removes the invalid leads from the capture system. All plaintiff documents MUST be signed for the lead to be sent to a firm. If the plaintiff does not sign all the documents, a firm is not sent the lead. No risk to the firm means Zero Risk signed cases.
• Once screened to ensure quality, a member of our Intake Team walks a prospect through the process. The potential client will sign the firm’s retainer and HIPPA documents. ForLawFirmsOnly Marketing, Inc., may also have a medical investigator review the case, get the firm’s retainer and HIPPA and HITECH releases signed and take photos when appropriate.

What ForLawFirmsOnly Marketing, Inc., can do for law firms:
• Provide Zero Risk signed cases that are to ready go at a fixed price
• Provide vetted plaintiffs who have signed on the firm’s dotted line
• Cut marketing costs and expenses while boosting revenues

Learn More About Why Law Firms Should Select ForLawFirmsOnly Marketing, Inc., as the Firm’s Primary Zantac Litigation Lead Agency.



For more information, press only:
PR Contact Name: Edward Lott, Ph.D., M.B.A.
Phone number: 855-943-8736 x-101 (Toll Free)
Email: edl@forlawfirmsonly.com
For more information on the Zero Risk Mass Tort Program™: https://www.forlawfirmsonly.com/

Edward Lott
ForLawFirmsOnly Marketing, Inc.
+1 855-943-8736
email us here

Zantac Lawsuit Signed Retainer Leads